Optimizing Donor Choice and GVHD Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

J Clin Oncol. 2021 Feb 10;39(5):373-385. doi: 10.1200/JCO.20.01771. Epub 2021 Jan 12.

Authors

Shernan G Holtan¹, Jurjen Versluis², Daniel J Weisdorf¹, Jan J Cornelissen²

Affiliations

¹ Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN.
² Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.

PMID: 33434075
DOI: 10.1200/JCO.20.01771

No abstract available

Publication types

Review

MeSH terms

Donor Selection / methods*
Donor Selection / standards
Graft vs Host Disease / prevention & control*
Hematopoietic Stem Cell Transplantation / methods*
Histocompatibility Testing / methods
Humans
Precision Medicine
Transplantation, Homologous